A dose-response relationship between the frequency of p53 mutations and tobacco consumption in lung cancer patients

Journal of Surgical Oncology

Volumn 61, Issue 1, 1996, Pages 20-26

  Kondo, Kazuya ^a   Tsuzuki, Hideo ^a   Sasa, Mitsunori ^a   Sumitomo, Masayuki ^a   Uyama, Tadashi ^a   Monden, Yasumasa ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

lung cancer; p53 gene; RT PCR SSCP; smoking

Indexed keywords

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HUMAN; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; ONCOGENE K RAS; POINT MUTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; SMOKING; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; FEMALE; GENES, P53; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SMOKING; SURVIVAL RATE;

EID: 0030021713     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199601)61:1<20::AID-JSO6>3.0.CO;2-U     Document Type: Article

References (29)

1. Ministry of Health and Welfare: "Statistics and Information Department. Vital Statistics 1988 Japan." Tokyo: Ministry of Health and Welfare, 1990.
2. Doll R, Hill AB: Mortality in relation to smoking: Ten years of observations of British doctors. Br Med J 1:1399-1410, 1964.
3. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61:759-767, 1990.
4. Shields PG, Harris CC: Principles of carcinogenesis: Chemical. In DeVita Jr VT, Hellman S, Rosenberg SA: "Cancer: Principles and Practice of Oncology, 4th ed." Philadelphia: J.B. Lippincott Co., 1993, pp 200-212.
5. Rodenhuis S, van de Watering ML, Mooi WJ, et al.: Mutational activation of the K-ras oncogene: A possible pathogenetic factor in adenocarcinoma of the lung. N Engl J Med 317:929-935, 1987.
6. Suzuki Y, Orita M, Siraishi M, et al.: Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 5:1037-1043, 1990.
7. Takahashi T, Nau MM, Chiba I, et al.: p53: A frequent target for genetic abnormalities in lung cancer. Science 246:491-494, 1989.
8. Takahashi T, Takahashi T, Suzuki H, et al.: The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern. Oncogene 6:1775-1778, 1991.
9. Chiba I, Takahashi T, Nau MM, et al.: Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene 5:1603-1610, 1990.
10. Kondo K, Umemoto A, Akimoto S, et al.: Mutations in the p53 tumour suppressor gene in primary lung cancer in Japan. Biochem Biophys Res Commun 183:1139-1146, 1992.
11. Miller CW, Simon K, Aslo A, et al.: p53 mutations in human lung tumors. Cancer Res 52:1695-1698, 1992.
12. Suzuki H, Takahashi T, Kuroishi T, et al.: p53 mutations in non-small cell lung cancer in Japan: Association between mutations and smoking. Cancer Res 52:734-736, 1992.
13. Slebos RJC, Hruban RH, Dalesio O, et al.: Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung J Natl Cancer Inst 83:1024-1027, 1991.
14. Mazur M, Glickman BW: Sequence specificity of mutations induced by benzo pyrene-7,8-diol-9,10-epoxide at endogenous apart gene in CHO cells. Somat Cell Mol Genet 14:393-400, 1988.
15. Union Internationale Contre le Cancer (UICC), Sherman CD (Chairman): "Manual of Clinical Oncology, 4th ed." Berlin: Springer-Verlag, 1987.
16. World Health Organization: "Histological Typing of Lung Tumours, 2nd ed." Geneva: World Health Organization, 1981.
17. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987.
18. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 253:49-53, 1991.
19. Mashiyama S, Sekiya T, Hayashi K: Screening of multiple DNA samples for detection of sequence changes. J Methods Mol Biol 12:304-306, 1990.
20. Sasa M, Kondo K, Komaki K, et al.: Frequency of spontaneous p53 mutations (CpG site) in breast cancer in Japan. Breast Cancer Res Treat 27:247-252, 1993.
21. Hayashi K: PCR-SSCP: A simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods Applications 1:34-38, 1991.
22. Gosney JR, Butt SA, Gosney MA, Field JK: Exposure to cigarette smoke and expression of the protein encoded by the p53 gene in bronchial carcinoma. Ann NY Acad Sci 28:243-247, 1993.
23. Ayesh R, Idle JR, Ritchie JC, et al.: Metabolic oxidation phenotypes as markers for susceptibility to lung cancer. Nature 312:169-170, 1984.
24. Westra WH, Offerhaus GJ, Goodman SN, et al.: Overexpression of the p53 tumor suppressor gene product in primary lung adenocarcinomas is associated with cigarette smoking. Am J Surg Pathol 17:213-220, 1993.
25. Kreyberg L: The significance of histological typing in the study of epidemiology of primary epithelial lung tumours. Br J Cancer 8:199-208, 1954.
26. Sozzi G, Miozzo M, Donghi R, et al.: Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res 52:6079-6082, 1992.
27. Mitsudomi T, Oyama T, Kusano T, et al.: Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer. J Natl Cancer Inst 85:2018-2023, 1993.
28. Horio Y, Takahashi T, Kuroishi T, et al.: Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer. Cancer Res 53:1-4, 1993.
29. Quinlan DC, Davidson AG, Summers CL, et al.: Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res 52:4828-4831, 1992